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Abstract
The well-known action of the gastric hormone gastrin in stimulating gastric
acid secretion is mediated by activation of cholecystokinin-2 receptors
(CCK2R). The latter are expressed by a variety of cell types suggesting that
gastrin is implicated in multiple functions. During wound healing in the
stomach CCK2R may be expressed by myofibroblasts. We have now charac-
terized CCK2R expression in cultured myofibroblasts. Immunocytochemistry
showed that a relatively small proportion (1–6%) of myofibroblasts expressed
the receptor regardless of the region of the gut from which they were derived,
or whether from cancer or control tissue. Activation of CCK2R by human
heptadecapeptide gastrin (hG17) increased intracellular calcium concentra-
tions in a small subset of myofibroblasts indicating the presence of a func-
tional receptor. Unexpectedly, we found over 80% of cells expressing CCK2R
were also labeled with 5-ethynyl-20-deoxyuridine (EdU) which is incorporated
into DNA during S-phase of the cell cycle. hG17 did not stimulate EdU
incorporation but increased migration of both EdU-labeled and unlabelled
myofibroblasts; the migratory response was inhibited by a CCK2R antagonist
and by an inhibitor of IGF receptor tyrosine kinase; hG17 also increased IGF-
2 transcript abundance. The data suggest myofibroblasts express CCK2R in a
restricted period of the cell cycle during S-phase, and that gastrin accelerates
migration of these cells; it also stimulates migration of adjacent cells probably
through paracrine release of IGF. Together with previous findings, the results
raise the prospect that gastrin controls the position of dividing myofibroblasts
which may be relevant in wound healing and cancer progression in the
gastrointestinal tract.
Introduction
In recent years myofibroblasts have emerged as important
determinants of mucosal organization in health and dis-
ease (Ohlund et al. 2014). The role of these cells in
wound healing in many different tissues is well-known
(Powell et al. 1999). In addition, however, a sheath of
myofibroblasts lies just under the basement membrane in
the gastrointestinal tract and is responsible for the secre-
tion of proteins involved in extracellular matrix formation
and turnover, as well as a range of growth factors includ-
ing insulin-like growth factors (IGF)-1 and -2 (Hemers
et al. 2005; Powell et al. 2005). In cancer, it is now clear
that modified myofibroblasts (cancer-associated myofi-
broblasts, CAMs) play a role in defining the cancer niche
and in influencing cancer progression (De Wever et al.
2008). These cells may originate by epithelial-mesenchy-
mal transition (McCracken et al. 2014), from inward
migration of bone-marrow derived mesenchymal stem
cells (Quante et al. 2011), or from tissue-resident cells
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including fibroblasts and pericytes (Hosaka et al. 2016).
The regulation of myofibroblast function remains incom-
pletely understood.
The pyloric antral hormone gastrin plays a central role
in regulating gastric acid secretion notably by stimulating
synthesis and secretion of histamine from enterochro-
maffin-like (ECL) cells which in turn stimulates acid
secretion by parietal cells (Dockray 2004). In addition,
gastrin regulates the growth of the oxyntic-gland mucosa
(Johnson 1976). This is most clearly seen in the hyper-
plasia of ECL cells that is associated with hypergastrine-
mia and which in extreme cases when accompanied by
inflammation or mutations of the MEN-1 gene may lead
to neuroendocrine (carcinoid) tumors (Burkitt et al.
2009). These actions of gastrin are mediated by the chole-
cystokinin-2 receptor (CCK2R) and are inhibited by
CCK2R antagonists (Fossmark et al. 2012; Moore et al.
2013). In addition, there is growing recognition of the
role of gastrin in gastrointestinal cancers including esoph-
agus, stomach, pancreas, and colon (Ferrand and Wang
2006); in some cases the evidence points to a role for gas-
trin acting at CCK2R but there is also evidence of a role
for nonclassical gastrins acting at other receptors (Kowal-
ski-Chauvel et al. 2012; Hayakawa et al. 2016).
The concept that tumors are wounds that do not heal
is well recognized (Dvorak 1986; Desmouliere et al.
2004). In this context it is notable that expression of
CCK2R occurs during wound healing in the stomach.
Schmassmann and Reubi (2000) used in situ hybridiza-
tion to show increased CCK2R in rat stomach following
cryo-ulceration; Ashurst et al. (2008) then showed that
after cryo-ulceration CCK2R expression was colocalized
with a-smooth muscle actin (a-SMA) which is a biomar-
ker for myofibroblasts (Desmouliere et al. 2004). The data
therefore raise the possibility that CCK2R is expressed in
activated myofibroblasts, but even so the significance of
this is poorly understood. We now report that in many
different gastrointestinal myofibroblasts there is transient
expression of CCK2R in S-phase of the cell cycle. We
have tested the hypothesis that gastrin regulates migration
of these cells in keeping with a role in determining cell
position after exit from the cell cycle. The data suggest a
novel dimension to understanding how gastrin might
control gastric mucosal architecture.
Materials and Methods
Cells
Unless otherwise stated experiments were performed on
human primary gastric CAMs previously generated from
patients undergoing surgery for gastric cancer (Holmberg
et al. 2012); some studies were also made on CAMs or
myofibroblasts from tissue adjacent to cancers (ATMs)
from colonic, pancreatic or esophageal cancer, normal tis-
sue myofibroblasts (NTMs) from healthy stomach and
esophagus, and myofibroblasts from chronic pancreatitis.
The patients and the myofibroblasts obtained from them
have all been described previously (Czepan et al. 2012;
Holmberg et al. 2012; Kemeny et al. 2013; Kumar et al.
2014). The work was approved by the Ethics Committee
of the University of Szeged, Szeged, Hungary and all sub-
jects gave informed consent. Myofibroblasts were cultured
as described previously and were used between passages 3
and 10 (Holmberg et al. 2012; Kemeny et al. 2013;
Kumar et al. 2014). AGS cells were obtained from Ameri-
can Type Culture Collection (Manassas, VA). Wild type
AGS cells were used together with stably transfected
clones expressing CCK2R (Varro et al. 2002).
Drugs, antibodies
L740093 was a gift from Dr R. Freidinger (Merck Sharpe
and Dohme, Rathway, New Jersey), AG1024 was obtained
from Calbiochem (Darmstadt, Germany), human unsul-
fated heptadecapeptide gastrin (hG17) from Bachem (St
Helens, Merseyside, UK), Click-iT EdU Imaging kit from
Invitrogen (Paisley, UK), CCK2R antibody from Atlas
Antibodies (HPA041976; Stockholm, Sweden), fluorescein
(FITC)-conjugated AffiniPure donkey anti-rabbit IgG was
from Jackson ImmunoResearch (West Grove, PA), Fluo-4
AM and Pluronic F-127 from Thermo Fisher Scientific
(Waltham, MA) and other chemicals from Sigma-Aldrich
(Poole, Dorset, UK),
Immunocytochemistry
Myofibroblasts were fixed with 4% w/v paraformaldehyde
(PFA) and processed for immunocytochemistry as previ-
ously described (Wroblewski et al. 2003; Kumar et al.
2014). Cells were permeabilized with 0.2% Triton X-100
in PBS followed by incubation with 5% w/v bovine serum
albumin in PBS, and blocking with 10% v/v donkey
serum. Myofibroblasts were stained with a CCK2R poly-
clonal antibody (1:200, overnight, 4°C) followed by incu-
bation with FITC-conjugated anti-rabbit secondary
antibody (1:400, 1 h, ambient temperature). In some
experiments, cells were incubated in SF medium or hG17
(10 nmol/L, 24 h) and stained with an antibody to cas-
pase-3 (New England Biolabs, Hertfordshire, UK). Slides
were mounted in Vectashield with 40,6-diamidino-2-phe-
nylindole dihydrochloride (DAPI) and images were
acquired using a Zeiss Axioplan-2 fluorescence micro-
scope (Zeiss Vision, Welwyn Garden City, UK). Images
were recorded at 109 and 439 magnification using Axio-
Vision software version 4.9.1.
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Microarray data
Microarray data on pairs of CAMs and corresponding
ATMs from 13 gastric cancer patients have previously
been deposited at http://www.ncbi.nlm.nih.gov/geo/query/
acc.cgi?acc=GSE44740. The TNM classification system
(Sobin et al. 2009) had been applied to these tumors
which had shown that patients with early stage disease
indicated by low lymph node involvement (pN0-1) had
significantly longer survival than those with advanced dis-
ease indicated by high lymph node involvement (pN2-4)
(51 vs. 12 months, respectively, P < 0.01) (Holmberg
et al. 2012; Balabanova et al. 2014). The present analysis
therefore focused on a comparison of CCK2R expression
in these two groups. The abundance of CCK2R tran-
scripts was expressed relative to GAPDH.
Intracellular calcium
Subconfluent cells were loaded with Fluo-4 AM ester
(2 lmol/L, 45 min, 37°C in HEPES saline buffer contain-
ing 10 mmol/L glucose, 1 mmol/L calcium, 200 lmol/L
sulphinpyrazone to reduce dye leakage and 25% w/v
Pluronic F-127 to increase cellular uptake of dye) as pre-
viously described (Homolya et al. 1993; Kao 1994). EGTA
(1 mmol/L) was added to the solution to reduce sponta-
neous calcium activity. Myofibroblasts were stimulated
with hG17 (10 nmol/L) or ionomycin (1 lmol/L) as a
positive control. Fluorescent signals were detected with a
Leica SP2 AOBS multiphoton confocal microscope
equipped with an argon-ion laser at 488 nm absorbance
and 516 nm emission peaks. Data analysis was carried
out in LAS X 2.0 software.
EdU incorporation
Proliferating cells were detected using 5-ethynyl-20-deox-
yuridine (EdU) as previously described (Holmberg et al.
2012; Kumar et al. 2016). Myofibroblasts were synchro-
nized by incubation in serum free (SF) media for 48 h
followed by treatment with medium containing 10% fetal
bovine serum (full medium, FM), or hG17, or fresh SF,
and incubation with EdU reagent for up to 24 h. After
EdU incorporation cells were fixed in paraformaldehyde
and processed using Click-iT™ Alexa Fluor 594 (300 lL)
according to the manufacturer’s instructions. Staining of
CCK2R was performed as described above.
Flow cytometry
Cultured cells were incubated in SF or FM for 48 h, or
were incubated in SF with or without hG17 (10 nmol/L,
24 h); cells were harvested and fixed in 4% PFA at 37°C
for 10 min prior to permeabilization with 90% methanol
for 30 min at 4°C. For cell cycle analysis, cells were
directly stained with DAPI (1 lg/mL). In experiments
aimed at detecting CCK2R, myofibroblasts were washed
twice with 0.5% BSA dissolved in 1xPBS and incubated
with CCK2R primary antibody (1:200, 1 h, ambient tem-
perature) and FITC-conjugated secondary antibody
(1:400, 30 min, ambient temperature) prior to nuclear
staining with DAPI. Cells were sorted with FACS Canto II
flow cytometer. CCK2R positive cells were separated
based on fluorescence excited at 492 nm.
Migration assays
Transwell migration and invasion assays were performed
using BD inserts or BD BioCoat™ Matrigel™ invasion
chambers (SLS, Nottingham, UK) with 1.3 or 2.5 9 104
cells per insert, respectively, as previously described
(Varro et al. 2004). Treatments including hG17 with or
without L740093 or AG1024 added to the lower well. In
some experiments EdU was added to the upper well and
cells were incubated overnight. Membranes were then
processed following the EdU protocol (see above) or
alternatively cells were stained with Quick-Diff (Reagena,
Toivala, Finland).
qPCR
RNA from control (SF) and gastrin (10 nmol/L, 24 h)
treated myofibroblasts was extracted in Tri-Reagent
(1.25 mL; Sigma, Dorset, UK) according to the manufac-
turer’s instructions. Pellets were resuspended in nuclease
free water (50 lL) and RNA (4 lg) reverse transcribed
with avian myeloblastosis virus reverse transcriptase and
oligo-dT primers (Promega). Real-time PCR was carried
out using an ABI7500 instrument (Applied Biosystems,
Warrington, UK) and TaqMan primer/probe sets for
human IGF-1, IGF-2 and GAPDH, together with Preci-
sion Plus 29 real-time PCR master mix (Primer Design,
Southampton, UK) and 50-FAM, 30-TAMRA double dye
probes (Eurogentec, Southampton, UK). Values were
standardized to GAPDH and assays included no-template
controls and a standard curve as previously described
(Kumar et al. 2015). Primers and probes for detection of
human IGF-1, IGF-2 and GAPDH, cDNAs were intron-
spanning and were: IGF-1: 50-TGT ATT GCG CAC CCC
TCA A-30 (forward), 50-CT CCC TCT ACT TGC GTT
CTT CA-30 (reverse), 50-ACA TGC CCA AGA CCC AGA
AGG AAG TAC A-30 (probe); IGF-2, 50-CCG TGC TTC
CGG ACA ACT T-30 (forward), 50-GGA CTG CTT CCA
GGT GTC ATA TT-30 (reverse), 50-CCC AGA TAC CCC
GTG GGC AAG TTC-30 (probe); GAPDH: 50-GCT CCT
CCT GTT CGA CAG TCA-30(forward), 50-ACC TTC
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CCC ATG GTG TCT GA-30 (reverse), 50-CGT CGC CAG
CCG AGC CAC A-30 (probe).
Statistics
Results are expressed as means  S.E. and comparisons
were made by ANOVA, t test or Fisher exact test, as
appropriate.
Results
CCK2R is expressed in a subset of
myofibroblasts
In initial experiments we validated the antibody used for
immunocytochemical localization of CCK2R by compar-
ison of wild type AGS cells (which do not express the
receptor) with their counterparts that have been stably
transfected with CCK2R, i.e AGS-Gr cells (Varro et al.
2002). As expected, the parental cell line was not stained;
however, AGS-Gr cells were strongly positive (Fig. 1A).
We then examined expression of CCK2R in a number of
myofibroblast populations recovered from normal tissue,
cancer or cancer-adjacent tissue from esophagus, stomach
or colon, or pancreatitis. In all cases, only a subpopula-
tion of cells were positive for CCK2R, ranging from 1 to
6% (Fig. 1B and C). We next examined the expression of
CCK2R in a microarray dataset (http://www.ncbi.nlm.nih.
gov/geo/query/acc.cgi?acc=GSE44740) of CAMs and
ATMs prepared from 13 patients with gastric cancer (Bal-
abanova et al. 2014). Interestingly, in patients with high
lymph node involvement (graded pN2-4), which corre-
lates with poor postoperative survival, the expression of
CCK2R was higher in 5 of 6 CAMs compared with their
matched ATMs, whereas in the subgroup with low lymph
node involvement (pN0-1) 6 of 7 CAMs expressed lower
CCK2R compared with their matched ATMs (Fig. 1D)
and the difference was statistically significant (P < 0.05,
Fisher exact test). Although the numbers are smaller, the
same picture can be seen in the immunocytochemical
data shown in Figure 1C where expression of CCK2R was
higher in CAMs compared with their matched ATMs
from patients with high lymph node involvement (S-
CAM4/ATM4, pN2; S-CAM1/ATM1, pN2) while the con-
verse is true for patients with low lymph node involve-
ment (S-CAM2/ATM2, pN0; S-CAM3/ATM3, pN1).
Gastrin increases intracellular calcium in a
subset of myofibroblasts
In order to determine whether myofibroblasts are capable
of mounting a functional response to gastrin we then
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Figure 1. Localization of CCK2R to a subset of myofibroblasts. (A)
Validation of antibody specificity: i) in wild type AGS cells, which do
not express CCK2R, there is no signal compared with ii) a strong
CCK2R signal in AGS-Gr cells which have been stably transfected
with a receptor-encoding construct (nuclei stained blue with DAPI).
(B) Myofibroblasts from several regions of the gastrointestinal tract
express CCK2R in a subset of cells; i), gastric cancer associated
myofibroblasts (CAMs); ii), normal stomach myofibroblasts. (C)
Expression in myofibroblasts from different regions of the gut (C,
colon; OE, esophagus; S, stomach; PI, chronic pancreatitis; P,
pancreatic cancer; ATM, adjacent tissue to cancer; NTM, normal
tissue myofibroblasts). (D) Abundance of CCK2R transcripts relative
to GAPDH in 13 pairs of CAMs and their corresponding ATMs from
gastric cancer patients, derived from microarray data. The patients
are divided into two groups depending on lymph node involvement
(pN0-1, n = 7; pN2-4, n = 6). Means  SE, horizontal arrows
significantly different P < 0.05.
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examined changes in intracellular calcium on administra-
tion of hG17. In myofibroblasts in SF medium, there was
labeling with Fluo-4 and no or infrequent spontaneous
fluctuations in intracellular calcium. Administration of
hG17 (10 nmol/L) produced a prompt increase in intra-
cellular calcium in a subset of gastric CAMs (5.3  1.4%
of total; 169 cells counted in three fields (Fig. 2A and B).
When the calcium ionophore was administered there was
a sustained increase in intracellular calcium in virtually all
cells.
CCK2R expression is associated with the cell
cycle
To determine whether CCK2R expression was influenced
by culture conditions, we incubated gastric CAMs in FM
or SF medium and examined expression by flow cytome-
try. The subset of cells expressing CCK2R amounted to
approximately 2% of total cells in FM, but when cells
were cultured in SF medium to depress proliferation, the
population of CCK2R-labelled cells was approximately
0.6% total (Fig. 3A). We then considered the hypothesis
that expression of CCK2R was dependent on the cell
cycle. As expected, cells incubated in FM exhibited signifi-
cantly higher labeling with EdU (which is incorporated
into DNA in S-phase) compared with cells in SF medium
(28.7  0.3 vs. 5.2  0.6% cells incorporating EdU,
respectively, P < 0.001). Interestingly, when we double-
labeled cells with EdU and CCK2R (Fig. 3B), over 80% of
cells expressing CCK2R were found to be labeled with
EdU. However, while the proportion of cells showing
EdU incorporation increased with duration of incubation
in FM the proportion of cells expressing CCK2R
remained relatively constant at 2–3% of total; similarly
the subpopulation of CCK2R positive cells that were not
labeled with EdU (<1% of total) remained relatively con-
stant (Fig. 3C).
Gastrin does not stimulate proliferation or
apoptosis of myofibroblasts
Since CCK2R expression was associated with EdU incor-
poration we then asked whether gastrin influenced EdU
incorporation. We found no significant difference in EdU
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Figure 2. Gastrin increases intracellular calcium in a subset of myofibroblasts. (A) Labeling of gastric CAMs with Fluo-4; i), control, ii)
stimulation with hG17 (10 nmol/L), arrows indicate responding cells; iii) effect of ionomycin (1 lmol/L). (B) hG17 (applied at I) stimulated a
transient increase in intracellular calcium in a subpopulation of gastric CAMs (a, b, c); ionomycin (applied at II) produced a sustained increase in
calcium in the majority of cells.
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incorporation in response to gastrin (Fig. 4A). Moreover
in flow cytometry, the proportions of cells in G0/G1, S or
G2/M phases of the cell cycle were not significantly differ-
ent after incubation with hG17 (Fig. 4B and C). Gastrin
also had no significant effect on caspase-3 labeling used
as a marker of apoptosis (Fig. 4D).
Gastrin stimulates migration and invasion
of EdU-labeled and unlabeled gastric
myofibroblasts
Since stimulation of myofibroblasts is linked to migration
and invasion, we then examined the effect of hG17 on
these responses using Boyden chambers. There was a clear
stimulation of both migration and invasion by hG17 that
was inhibited by the CCK2R antagonist L740093 (Fig. 5A
and B). To further characterize the migrating cells we
examined whether they incorporated EdU. There was
indeed hG17-stimulated migration of EdU labeled cells
that was inhibited by L740093 (Fig. 5C and D). However,
only about 40% of the migrating cells were labeled with
EdU suggesting that cells expressing CCK2R were also
able to activate other cells via a paracrine pathway. A role
for IGF in mediating autocrine/paracrine signaling in
myofibroblasts is well-established (Hemers et al. 2005;
McCaig et al. 2006), and consistent with this we found
the IGF receptor tyrosine kinase inhibitor AG1024 sup-
pressed hG17-stimulated migration, and to a lesser extent
invasion (Fig. 5E). Finally, in the presence of hG17 the
relative abundance of IGF-2 transcripts was 2.1  0.1 fold
higher than control (P < 0.05); IGF-1 transcript abun-
dance was virtually undetectable in these cells.
Discussion
In the normal gastrointestinal tract, CCK2R expression is
localized to parietal cells, ECL cells, an LGR5 + antral
stem cell population, smooth muscle and some enteric
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neurons (Dufresne et al. 2006; Hayakawa et al. 2016).
However, in wound healing there is induction of CCK2R
in cells of a fibroblastic lineage which may include myofi-
broblasts (Schmassmann and Reubi 2000; Ashurst et al.
2008). The main finding of the present study is that
CCK2R is expressed in myofibroblasts from different
parts of the gut while the cells are in S-phase of the cell
cycle. The receptor appears to be functional and stimula-
tion is associated with increased intracellular calcium and
increased migration and invasion. Taken together it
appears that expression of CCK2R may provide a mecha-
nism that allows gastrin to determine the position of
myofibroblasts as they progress through the cell cycle
which might be particularly relevant during wound heal-
ing or in cancer.
There are well-known issues regarding interpretation of
immunocytochemical studies with antibodies to G-protein
coupled receptors (GPCRs) (Baker 2015). The antibody
we employed was validated by the finding that wild type
AGS cells (which do not express the receptor) were
unstained while there was a strong signal in those cells
that were stably transfected with CCK2R. Similar results
(not shown) have also been obtained with an esophageal
cell line (OE33 cells) transfected with the receptor (Haigh
et al. 2003). These findings therefore provide direct sup-
port for the specificity of the antibody in localizing
CCK2R.
The expression of CCK2R varied from 1 to 6% of cells
in different myofibroblast lines. However, expression of
CCK2R was higher in CAMs compared with their corre-
sponding ATMs in patients with advanced gastric cancer
and in these circumstances CAMs are known to have
higher rates of proliferation (Holmberg et al. 2012),
moreover a high proportion of CCK2R expressing cells
incorporated EdU which corresponds to S-phase of the
cell cycle. Although the proportion of CCK2R-expressing
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Figure 4. Gastrin does not stimulate proliferation or apoptosis in myofibroblasts. (A) Incubation in hG17 (10 nmol/L, 24 h) had no effect on
EdU incorporation. (B) Representative flow cytometry profiles show no effect of incubation in hG17 on the proportion of cells in G0/G1, S or
G2/M. (C) Quantification of cells in G0/G1, S or G2/M by flow cytometry in three separate experiments. (D) Staining with antibody to caspase-3
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cells appears relatively low, it is similar to the proportion
determined to be in S-phase from flow cytometry.
Because EdU incorporation into DNA is stable, labeled
cells correspond to those that were in S-phase at some
stage during the labeling period. This is likely to account
for the observation that while most CCK2R-expressing
cells were also labeled with EdU, there were nevertheless
populations of EdU labeled cells that were CCK2R nega-
tive (i.e corresponded to cells that had since left S-phase
and ceased expressing the receptor). The data indicate,
therefore, that CCK2R expression in myofibroblasts is
transiently associated with S-phase although in a formal
sense we cannot exclude the possibility that there are two
distinct populations of cells, one of which expresses
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Figure 5. Gastrin stimulates myofibroblast migration and invasion. (A) Representative Boyden chamber images showing migration (top) and
invasion (bottom) in response to hG17 (10 nmol/L), L740093 (50 lmol/L), and the combination. (B) hG17 stimulates both cell migration (left)
and invasion (right) of myofibroblasts in Boyden chambers and the response is inhibited by the CCK2R antagonist, L740093; y-axis mean  SE
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CCK2R during S-phase and the other which does not.
However, while a relatively small proportion of cells may
be expressing CCK2R at any one point in time, expres-
sion restricted to S-phase means that all cells in this pop-
ulation do indeed express CCK2R, albeit transiently. Thus
looking at overall frequency of expression at a single time
point may be misleading.
The GPCR agonists that are linked to increases in
intracellular calcium are also mitogens for many different
cell types where proliferative responses may reflect trans-
activation of the EGF receptor (Prenzel et al. 1999; Varro
et al. 2002). In cells of fibroblastic lineages there is an
association among cell shape, cell cycle progression, and
calcium influx (Pennington et al. 2007). For the most
part the focus of previous work in this area has been on
progression from the checkpoint to S-phase. The selective
expression of GPCRs that serve to increase intracellular
calcium only in S-phase suggests mechanisms that are
more complex than previously supposed. Our observa-
tions suggest that gastrin does not influence either EdU
incorporation during S-phase or progression through G-2
to mitosis. This is interesting not least because the situa-
tion appears to be different for some other GPCRs that
exhibit cell-cycle dependent regulation of expression. For
example the chemokine receptor CXCR3 is expressed in
both S and G2-M phases in human microvascular
endothelial cells (Romagnani et al. 2001); moreover,
expression of GPR19 in lung cancer cells is triggered by
entry into S-phase and in this case seems to promote pro-
gression from G2 to M phase (Kastner et al. 2012).
The capacity of CCK2R/EdU labeled cells to respond to
gastrin in chemotaxis assays provides direct evidence that
the receptor is linked to a functional response. Interest-
ingly, in these experiments there was also increased
migration of unlabelled cells. As already mentioned, it is
established that gastrin activates a number of paracrine
signaling cascades in epithelial cells including EGF-family
members, FGF-2, IL-8, and prostaglandins (Varro et al.
2002, 2004; Noble et al. 2003). The present data suggest
gastrin may also target the IGF system which is important
for mediating paracrine mechanisms initiated by gastroin-
testinal myofibroblasts (Hemers et al. 2005; McCaig et al.
2006). Thus, we show here that the IGF receptor tyrosine
kinase inhibitor blocked the paracrine effect of gastrin on
migration of unlabelled cells, moreover gastrin increased
IGF-2 transcript abundance. Whether there are other
mediators requires further work.
In experimental studies in rat, CCK2R is expressed dur-
ing wound healing in the stomach (Schmassmann and
Reubi 2000); in addition to epithelial cell expression the
evidence indicates that several days after injury CCK2R is
expressed in submucosal cells that express the myofibrob-
last marker, a-SMA (Ashurst et al. 2008). The
mechanisms regulating expression have been studied in
cultured epithelial cells where it has been shown that
serum starvation and gastrin itself increase CCK2R
expression (Ashurst et al. 2008). It now seems likely that
different mechanisms regulate CCK2R expression in dif-
ferent cell types and at present it would appear that the
association between expression and S-phase of the cell
cycle is a property of myofibroblasts. Given the impor-
tance of myofibroblasts in tissue repair the expression of
CCK2R may well underpin the gastrin-stimulated wound
healing observed in animal models (Schmassmann and
Reubi 2000).
There has been growing interest in the role of gastrin
in promoting cancer progression (Ferrand and Wang
2006; Kovac et al. 2009; Boyce et al. 2017). In part, this
work has been directed at the nonclassical gastrins that
are thought not to act at CCK2R. The situation is not
clear cut, however, since there may be a role for CCK2R
in mediating the effects of progastrin (which is not a clas-
sical CCK2R agonist) on colon cancer progression (Jin
et al. 2009). To the extent that research in this area has
been directed at CCK2R expression it has generally been
focused on receptor expression by either cancer cells or
normal epithelial cells, including stem cells. The idea that
CCK2R might also be transiently expressed in myofibrob-
lasts adds a new dimension, which is of particular interest
in view of the emerging consensus that the microenviron-
ment is an important determinant of cancer progression
(De Wever et al. 2008; Hanahan and Weinberg 2011;
Quail and Joyce 2013).
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